ArticleMedicine2025

Identification of therapeutic targets for rheumatic heart valve disease based on systematic druggable genome wide Mendelian randomization.

Wei-Hua Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.